| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5685359 | American Journal of Kidney Diseases | 2017 | 9 Pages | 
Abstract
												Patients initiating HD therapy in facilities almost exclusively using iron sucrose versus ferric gluconate had similar longer-term outcomes. However, there was a small decrease in infectious hospitalizations and deaths in patients dialyzing in facilities predominantly using iron sucrose. This difference may be due to residual confounding, random chance, or a causal effect.
											Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Nephrology
												
											Authors
												Wolfgang C. MD, MPH, ScD, Benjamin A. PhD, Aya A. MPH, Victoria Y. MSc, Medha MD, Sreedhar MD, MPH, Tara I. MD, MSc, M. Alan PhD, Steven MD, 
											